CRO appears to be rounding off, meeting with pre-Bullrun support levels.
There is still room for a 15-22% move to the downside before the floor would be met, so trade cautiously. Cost averaging may be the best approach with this one.
Long term future for the company is still strong with news of expansion across multiple new countries.
It's worth bearing in mind that a lot of hope has been lost by a large number of CRO supporters and early investors. However, CRO has secured its place in the market, and will very likely ride off of the back of Bitcoins success if and when it breaks above it's previous ATH ($19,665).
With a large marketing budget and an attractive domain, it's not hard to believe that there may be a second CRO bull-run.
If so, the next few weeks will make for a perfect accumulation zone, if the TA is to be correct.
There is still room for a 15-22% move to the downside before the floor would be met, so trade cautiously. Cost averaging may be the best approach with this one.
Long term future for the company is still strong with news of expansion across multiple new countries.
It's worth bearing in mind that a lot of hope has been lost by a large number of CRO supporters and early investors. However, CRO has secured its place in the market, and will very likely ride off of the back of Bitcoins success if and when it breaks above it's previous ATH ($19,665).
With a large marketing budget and an attractive domain, it's not hard to believe that there may be a second CRO bull-run.
If so, the next few weeks will make for a perfect accumulation zone, if the TA is to be correct.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.